Literature DB >> 9534942

Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats.

L S Matsubara1, B B Matsubara, M P Okoshi, M Franco, A C Cicogna.   

Abstract

The aim of the present study was to evaluate the effect of interstitial fibrosis alone or associated with hypertrophy on diastolic myocardial function in renovascular hypertensive rats. Myocardial function was evaluated in isolated papillary muscle from renovascular hypertensive Wistar rats (RHT, n = 14), renovascular hypertensive rats treated with the angiotensin converting enzyme inhibitor (ACEI) ramipril, 20 mg.kg-1.day-1 (RHT RAM, n =14), and age-matched unoperated and untreated Wistar rats (CONT, n = 12). The ACEI treatment for 3 weeks allowed the regression of myocyte mass and the maintenance of interstitial fibrosis. Myocardial passive stiffness was analyzed by the resting tension-length relationship. The myocardial fibrosis was evaluated by measuring myocardial hydroxyproline (Hyp) concentration and by histological studies of the myocardium stained with hematoxylin and eosin or picrosirus red. Left ventricular weight was significantly higher in RHT (0.97 +/- 0.12 g) compared with CONT (0.66 +/- 0.06 g) and RHT RAM (0.69 +/- 0.14 g). The Hyp levels were 2.9 +/- 0.4, 3.4 +/- 0.3, and 3.8 +/- 0.4 micrograms/mg of dry tissue for the CONT, RHT, and RHT RAM, respectively. Perivascular and interstitial fibrosis were observed in RHT and RHT RAM groups. There were lymphononuclear inflammatory exudate and edema around arteries, involving adjacent myocytes in the RHT group. There was an increased passive stiffness in RHT and RHT RAM groups compared with the CONT group. In conclusion, our results indicate that the impaired diastolic function in the renovascular hypertensive rats is related to interstitial fibrosis rather than to myocardial hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9534942

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  7 in total

1.  Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus.

Authors:  Camila Moreno Rosa; Dijon Henrique Salome Campos; David Rafael Abreu Reyes; Felipe Cesar Damatto; Lucas Yamada Kurosaki; Luana Urbano Pagan; Mariana Janini Gomes; Camila Renata Corrêa; Ana Angelica Henrique Fernandes; Marina Politi Okoshi; Katashi Okoshi
Journal:  Antioxidants (Basel)       Date:  2022-05-17

2.  Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.

Authors:  C M Rosa; R Gimenes; D H S Campos; G N Guirado; C Gimenes; A A H Fernandes; A C Cicogna; R M Queiroz; I Falcão-Pires; D Miranda-Silva; P Rodrigues; F R Laurindo; D C Fernandes; C R Correa; M P Okoshi; K Okoshi
Journal:  Cardiovasc Diabetol       Date:  2016-09-01       Impact factor: 9.951

Review 3.  A Review of the Roles and Limitations of Noninvasive Imaging Methods for Investigating Cardiovascular Disease in Individuals with Obesity.

Authors:  Rosana Marssaro Cortez; Marina Politi Okoshi; Katashi Okoshi
Journal:  Med Sci Monit       Date:  2022-07-30

4.  Aerobic Exercise During Advance Stage of Uncontrolled Arterial Hypertension.

Authors:  Luana U Pagan; Mariana J Gomes; Ricardo L Damatto; Aline R R Lima; Marcelo D M Cezar; Felipe C Damatto; David R A Reyes; Dijon H S Campos; Tulio M M Caldonazo; Bertha F Polegato; Denise C Fernandes; Francisco R Laurindo; Ana A H Fernandes; Ana Lloret; Antonio C Cicogna; Marina P Okoshi; Katashi Okoshi
Journal:  Front Physiol       Date:  2021-06-03       Impact factor: 4.566

5.  Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus.

Authors:  R Gimenes; C Gimenes; C M Rosa; N P Xavier; D H S Campos; A A H Fernandes; M D M Cezar; G N Guirado; L U Pagan; I D Chaer; D C Fernandes; F R Laurindo; A C Cicogna; M P Okoshi; K Okoshi
Journal:  Cardiovasc Diabetol       Date:  2018-01-17       Impact factor: 9.951

6.  The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study.

Authors:  Wassim Mosleh; Milind R Chaudhari; Swati Sonkawade; Supriya Mahajan; Charl Khalil; Kevin Frodey; Tanvi Shah; Suraj Dahal; Roshan Karki; Rujuta Katkar; W Matthijs Blankesteijn; Brian Page; Saraswati Pokharel; Minhyung Kim; Umesh C Sharma
Journal:  Biomark Insights       Date:  2018-05-03

7.  The protective effects of liguzinediol on congestive heart failure induced by myocardial infarction and its relative mechanism.

Authors:  Qi Chen; Dini Zhang; Yunhui Bi; Weiwei Zhang; Yuhan Zhang; Qinghai Meng; Yu Li; Huimin Bian
Journal:  Chin Med       Date:  2020-06-15       Impact factor: 5.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.